Clinical Trial

Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events

Study acronym: CorCal
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to test the effectiveness of a proactive cardiovascular primary prevention strategy, with or without the use of coronary calcium screening, compared to current standard care, in preventing future major adverse cardiac events (MACE), including all-cause death, non-fatal myocardial infarction (MI), stroke, or any arterial revascularization among a moderate risk population with no current evidence of cardiovascular disease.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2018-02-14; most recent amendment 2026-04-09.
Status change: Recruiting → Active, Not Recruiting 2025-05-01
Status change: Not Yet Recruiting → Recruiting 2018-03-05
Trial Details
NCT Number NCT03439267
Lead Sponsor Intermountain Health Care, Inc.
Conditions Cardiovascular Primary Prevention Strategy
Enrollment 5,765 participants
Start Date 2018-03-26
Primary Completion 2026-04-06 (estimated)
Study Completion 2027-04-06 (estimated)
Updated on ClinicalTrials.gov 2026-04-14